Molecular Cancer Therapeutics Molecular Diagnostics in Cancer Therapeutic Development: Fulfilling the Promise of Personalized Medicine Bridging the Lab and the Clinic in Cancer Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, P. H.
Right arrow Articles by Monforte, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, P. H.
Right arrow Articles by Monforte, J.
Vol. 1, 1293-1304, December 2002     Molecular Cancer Therapeutics
© 2002 American Association for Cancer Research

Multiplex Gene Expression Analysis for High-Throughput Drug Discovery: Screening and Analysis of Compounds Affecting Genes Overexpressed in Cancer Cells 1

Paul H. Johnson2, Roger P. Walker3, Steven W. Jones, Kathy Stephens4, Janet Meurer, Deborah A. Zajchowski, May M. Luke5, Frank Eeckman6, Yuping Tan4, Linda Wong3, Gordon Parry, Thomas K. Morgan, Jr., Meg A. McCarrick7 and Joseph Monforte8

Departments of Cancer Research [P. H. J., D. A. Z., M. M. L., G. P., M. A. M.], Molecular Pharmacology [S. W. J., J. Me.], and Medicinal Chemistry [T. K. M., M. A. M.], Berlex Biosciences, Richmond, California 94804-0099, and GeneTrace Systems, Inc., Alameda, California 94502 [R. P. W., K. S., F. E., Y. T., L. W., J. Mo.]

Drug discovery strategies are needed that can rapidly exploit multiple therapeutic targets associated with the complex gene expression changes that characterize a polygenic disease such as cancer. We report a new cell-based high-throughput technology for screening chemical libraries against several potential cancer target genes in parallel. Multiplex gene expression (MGE) analysis provides direct and quantitative measurement of multiple endogenous mRNAs using a multiplexed detection system coupled to reverse transcription-PCR. A multiplex assay for six genes overexpressed in cancer cells was used to screen 9000 chemicals and known drugs in the human prostate cancer cell line PC-3. Active compounds that modulated gene expression levels were identified, and IC50 values were determined for compounds that bind DNA, cell surface receptors, and components of intracellular signaling pathways. A class of steroids related to the cardiac glycosides was identified that potently inhibited the plasma membrane Na+K+-ATPase resulting in the inhibition of four of the prostate target genes including transcription factors Hoxb-13, hPSE/PDEF, hepatocyte nuclear factor-3{alpha}, and the inhibitor of apoptosis, survivin. Representative compounds selectively induced apoptosis in PC-3 cells compared with the nonmetastatic cell line BPH-1. The multiplex assay distinguished potencies among structural variants, enabling structure-activity analysis suitable for chemical optimization studies. A second multiplex assay for five toxicological markers, Hsp70, Gadd153, Gadd45, O6-methylguanine-DNA methyltransferase, and cyclophilin, detected compounds that caused DNA damage and cellular stress and was a more sensitive and specific indicator of potential toxicity than measurement of cell viability. MGE analysis facilitates rapid drug screening and compound optimization, the simultaneous measurement of toxicological end points, and gene function analysis.




This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
N. Arrach, S. Porwollik, P. Cheng, A. Cho, F. Long, S.-H. Choi, and M. McClelland
Salmonella Serovar Identification Using PCR-Based Detection of Gene Presence and Absence
J. Clin. Microbiol., August 1, 2008; 46(8): 2581 - 2589.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
T. Mijatovic, N. De Neve, P. Gailly, V. Mathieu, B. Haibe-Kains, G. Bontempi, J. Lapeira, C. Decaestecker, V. Facchini, and R. Kiss
Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity
Mol. Cancer Ther., May 1, 2008; 7(5): 1285 - 1296.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. C. Cheng, K. M. Sakamoto, E. M. Horwitz, S. L. Karsten, L. Shoemaker, H. I. Kornblumc, and P. Malik
Report on the Workshop "New Technologies in Stem Cell Research," Society for Pediatric Research, San Francisco, California, April 29, 2006
Stem Cells, April 1, 2007; 25(4): 1070 - 1088.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
M. G. Muszynski, T. Dam, B. Li, D. M. Shirbroun, Z. Hou, E. Bruggemann, R. Archibald, E. V. Ananiev, and O. N. Danilevskaya
delayed flowering1 Encodes a Basic Leucine Zipper Protein That Mediates Floral Inductive Signals at the Shoot Apex in Maize
Plant Physiology, December 1, 2006; 142(4): 1523 - 1536.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
E. P. Garcia, L. A. Dowding, L. W. Stanton, and V. I. Slepnev
Scalable Transcriptional Analysis Routine--Multiplexed Quantitative Real-Time Polymerase Chain Reaction Platform for Gene Expression Analysis and Molecular Diagnostics
J. Mol. Diagn., October 1, 2005; 7(4): 444 - 454.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Langenhan, N. R. Peters, I. A. Guzei, F. M. Hoffmann, and J. S. Thorson
Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization
PNAS, August 30, 2005; 102(35): 12305 - 12310.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. J. Lee, J. A. Robinson, N. A. Holman, M. N. McCall, S. J. Roberts-Thomson, and G. R. Monteith
Antisense-mediated Inhibition of the Plasma Membrane Calcium-ATPase Suppresses Proliferation of MCF-7 Cells
J. Biol. Chem., July 22, 2005; 280(29): 27076 - 27084.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
H. Tian, L. Cao, Y. Tan, S. Williams, L. Chen, T. Matray, A. Chenna, S. Moore, V. Hernandez, V. Xiao, et al.
Multiplex mRNA assay using electrophoretic tags for high-throughput gene expression analysis
Nucleic Acids Res., September 8, 2004; 32(16): e126 - e126.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
J.-B. Fan, J. M. Yeakley, M. Bibikova, E. Chudin, E. Wickham, J. Chen, D. Doucet, P. Rigault, B. Zhang, R. Shen, et al.
A Versatile Assay for High-Throughput Gene Expression Profiling on Universal Array Matrices
Genome Res., May 1, 2004; 14(5): 878 - 885.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Jung, R.-S. Kim, S.-J. Lee, C. Wang, and M.-H. Jeng
HOXB13 Homeodomain Protein Suppresses the Growth of Prostate Cancer Cells by the Negative Regulation of T-Cell Factor 4
Cancer Res., May 1, 2004; 64(9): 3046 - 3051.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
K. L. Gunderson, S. Kruglyak, M. S. Graige, F. Garcia, B. G. Kermani, C. Zhao, D. Che, T. Dickinson, E. Wickham, J. Bierle, et al.
Decoding Randomly Ordered DNA Arrays
Genome Res., May 1, 2004; 14(5): 870 - 877.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.